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ODERN diagnostic techniques allow the de-
tection of many potentially dangerous condi-
tions before patients get sick, often before symptoms



















 — has led
to controversy about preventive treatment. All four
are serious disorders that can cause disabling or fatal
brain infarction or hemorrhage. Treatment of these
conditions — surgery in patients with carotid artery
disease, aneurysms, or vascular malformations and
anticoagulant therapy in elderly persons with atrial
fibrillation — carries considerable risks as well as po-





 and many physicians as
well as patients endorse the adage, “If it ain’t broke,
don’t fix it,” and note that you cannot make an asymp-
tomatic person feel better. Other doctors, however,
want to repair any lesion that exists. The issues raised
are broad, and they hinge on the question: How do
doctors decide to treat individual patients?
Choosing surgery for patients with an unruptured
intracranial aneurysm involves weighing the risk of
intracranial hemorrhage against the risks associated





findings of the International Study of Unruptured





tors retrospectively analyzed the frequency of rupture
among 1449 patients with unruptured intracranial
aneurysms, some of which were discovered during
the treatment of subarachnoid hemorrhage caused
by the rupture of other aneurysms.
Size, location, and previous subarachnoid hemor-
rhage were the most important features that predicted
aneurysmal rupture. As in other circumstances, bio-
logic characteristics proved to be very important. Pa-
tients with previously ruptured aneurysms had 11
times the rate of rupture of patients without prior
hemorrhage. The size of the aneurysm was prognos-
tically important. Aneurysms that were less than 10
mm in diameter had a very low rate of rupture. Loca-
tion was also important. Aneurysms at the junction
of the internal carotid and posterior communicating
arteries and aneurysms within the vertebrobasilar
system, especially those at the rostral basilar-artery




The study also analyzed surgery-related morbidity
and mortality among 1172 patients with newly diag-
nosed, unruptured intracranial aneurysms. The out-
come of surgery depended heavily on age. The com-
bined rate of surgery-related morbidity and mortality
at one year for patients without prior subarachnoid
hemorrhage was 6.5 percent for those younger than
45 years, 14.4 percent for those between 45 and 64
years, and 32 percent for those over 64. The authors
concluded that the risks of surgery outweighed the
benefits in patients without previous subarachnoid
bleeding who had aneurysms that were less than 10
mm in diameter.
Previous studies performed at the Mayo Clinic
also emphasized size as the main prognostic feature.
In a study of 65 patients with 81 unruptured aneu-
rysms, reported in 1981, none of the 44 aneurysms
that were 10 mm in diameter or less ruptured, as





 In a study of 130 patients with 161
unruptured aneurysms, reported in 1987, saccular
aneurysms that were less than 10 mm in diameter
had a very low rate of rupture; the mean diameter of





diameter of ruptured aneurysms at the Mayo Clinic




 Other large studies
have shown that small aneurysms may cause sub-
arachnoid hemorrhage, however. In the Co-opera-
tive Study of Intracranial Aneurysms and Subarach-
noid Hemorrhage, which involved 6038 ruptured
aneurysms, the critical size for rupture was between




 In another study, involving 650 pa-
tients with aneurysmal rupture, the average size of




Intracranial aneurysms cause symptoms other than
clinically recognized subarachnoid hemorrhage. Ep-
isodes of minor bleeding, often referred to as senti-





 Some aneurysms produce
pressure on cranial nerves and brain structures, caus-
ing headache and neurologic symptoms and signs.
Aneurysms can harbor thrombi that embolize distal-





quency of symptoms other than recognized rupture




There are many characteristics that prudent physi-
cians must weigh in each individual case. The size and
location of the aneurysm and the presence or absence
of a history of ruptured aneurysms are important. The
patient’s symptoms should also be considered. Major
compressive symptoms should lead to the consider-
ation of surgery. Coexisting medical problems are
common in patients with aneurysms. Hypertension
increases the risk of bleeding. Poorly controlled hy-
pertension, especially in patients known to be non-
compliant with treatment, is therefore a factor that
favors surgery. Severe cardiac, pulmonary, or renal
disease or cancer weighs against prophylactic surgery.
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Factors related to surgery are also critical. The location
of some aneurysms makes surgery particularly diffi-
cult and hazardous. The morphologic features of the
aneurysm — for example, whether it has a neck that
can be clipped — also influence the outcome of sur-
gery. And of course, some surgeons have better results
with respect to morbidity and mortality than others.
There are also many patient-related factors. Age is
very important. Surgery seems more reasonable in
young patients, who face many years at risk, than in
older patients. The patient’s feelings, experiences, bi-
ases, and personal preferences are also important.
Many patients will not accept the immediate risk of
death or disability associated with surgery to prevent
the possibility of rupture at some time in the future.
On the other hand, some patients are so frightened
by knowing that they have an aneurysm (“a time
bomb ticking in my head”) that they cannot func-
tion until it is repaired.
How do physicians make such difficult therapeutic
decisions? Evidence-based medicine emphasizes the
importance of relying on data from randomized ther-
apeutic trials. But many conditions are not suitable
for a randomized trial, which requires that the con-
dition be common, with clear end points that occur
within a relatively short period. There have been no
such trials of patients with unruptured aneurysms.
Even when information from trials is available, it may
not be useful in individual cases. To acquire samples
large enough to yield statistically significant results,
investigators often combine various subgroups of pa-
tients. The results are generally valid but not neces-
sarily easily applied to particular patients. Patients who
are old or frail, those with coexisting conditions, and
women of childbearing age are frequently excluded.
(Almost three quarters of the patients with unrup-





But the excluded patients are often representative of
those who turn up in doctors’ offices. In addition, pa-
tients in trials often receive treatment in academic
hospitals, and the surgeons chosen to participate in
the trials have records of very low mortality and mor-
bidity rates. Patients in trials receive specialized atten-
tion. The same may not be true in the community,
where many patients are treated.
A decision whether to treat an unruptured intra-
cranial aneurysm surgically, like many other difficult
therapeutic decisions, requires the wisdom of Solo-
mon. Physicians should review all the relevant data
from trials and natural-history studies. They must also
get to know their patients and their particular condi-
tions, coexisting disorders, and desires. Some pa-
tients welcome statistical data and choose therapies
logically on the basis of such data. Others eschew
“science” and rely on alternative therapies. Decisions
take time, patience, experience, and repeated visits
with patients. But these key ingredients are not val-
ued highly in our money-driven system of medical
care. Yes, the size of unruptured aneurysms matters
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EMOLYTIC disease of the fetus and newborn
was first described in 1609 in a set of twins by a
French midwife: the first twin was hydropic and still-
born, and the second was deeply jaundiced and sub-
sequently died of what we now call kernicterus. The
two conditions were not associated again until 1932,
when Diamond et al. demonstrated that hydrops and
kernicterus were two aspects of the same disease in
which hemolysis of the red cells of fetuses and neo-
nates resulted in extramedullary erythropoiesis, caus-
ing hepatosplenomegaly and an outpouring of eryth-





 Kernicterus was subsequently
shown to be due to the deposition of unconjugated
bilirubin in the brain. It is usually fatal; the 10 percent
of affected infants who survive have spastic choreo-
athetosis, deafness, and mental retardation.
H
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The identification of the cause of the hemolysis
had to await the discovery of the Rh system in 1940
and the determination soon thereafter that hemolytic
disease of the fetus occurred in an RhD-positive
fetus carried by an RhD-negative woman who had
been immunized by transplacental passage of RhD-





IgG antibodies to RhD traverse the placenta, coat-
ing and destroying the RhD-positive fetal red cells and
initiating the chain of events that leads to death from
hydrops in 25 percent of affected fetuses and death
from kernicterus in 25 percent of affected neonates.
In the early 1940s in Canada, when the perinatal
death rate was 40 per 1000 births, 10 percent of the
deaths were due to hemolytic disease of the new-
born. In Manitoba there were 90 to 100 such deaths





 in which an infant’s RhD-
positive red cells are replaced by red cells from an
RhD-negative donor, offered a means of preventing
hemolysis and kernicterus and of cutting the mortal-
ity rate of hemolytic disease of the newborn in half.
The remaining problem was hydrops fetalis: half
of the cases occurred at or before 34 weeks’ gesta-
tion and half afterward. The induction of labor or
delivery by cesarean section at or after 32 weeks’
gestation, which substituted the lesser risks posed by
prematurity for the greater risks associated with hy-
drops, substantially reduced perinatal mortality. How-
ever, the accuracy of the diagnosis of hemolytic disease
in utero was poor, which meant that some prema-
turely delivered babies were unaffected or only mild-
ly affected and died of prematurity and that others
were left in utero and became hydropic.
In 1961, the introduction of the spectrophoto-
metric measurement of bilirubin in amniotic fluid as
an index of hemolysis increased the accuracy of the




By 1964, the death rate from hemolytic disease of
the newborn in Manitoba had been reduced from
25 percent of all affected infants to 16 percent. The
introduction of fetal ultrasonography in the late
1970s and of fetal-blood sampling in the early 1980s
further improved the accuracy of fetal diagnosis. The









 further lowered the
death rate to 2 percent in Manitoba in the 10-year
period from 1986 to 1995.
When the father of a fetus being carried by a sen-
sitized RhD-negative woman is heterozygous for
RhD, as more than 50 percent of people are, the cli-
nician is on the horns of a dilemma. Half the fetuses
will be RhD-negative and therefore require no treat-
ment. The others will be RhD-positive and require
sophisticated investigative measures and treatments.
The RhD status of the fetus can usually be deter-
mined by serial measurements of bilirubin in amni-
otic fluid or by measuring the hemoglobin concen-
tration in fetal blood. Both these approaches are
invasive and carry some risk of fetal trauma and of
fetomaternal transfer of blood, which will increase
the titer of antibodies to RhD if the fetus is RhD-
positive. Unfortunately, ultrasonography to deter-
mine the size of the placenta and the size of the fetal
liver may fail to identify an RhD-positive fetus until
hydrops has occurred.
Analysis of amniotic fluid DNA by the polymerase
chain reaction (PCR) to determine the fetal RhD




 is very accurate but is also
invasive. The use of PCR analysis to detect fetal nu-
cleated erythroid precursors in maternal blood proved
to be frequently but not always accurate as well as time








 Lo et al. describe a
noninvasive method of determining fetal RhD status




 Using a fluorescence-
based PCR assay that was sensitive enough to detect
the amount of RhD DNA found in a single cell,
these researchers determined the RhD status of sin-
gleton fetuses from 57 RhD-negative women whose





method correctly identified the RhD status of 10 of
12 fetuses whose mothers were in their first trimester
of pregnancy, that of all 30 fetuses whose mothers
were in their second trimester, and that of all 15 fe-
tuses whose mothers were in their third trimester.
The method they describe is rapid, providing results
within one day, and represents a major advance in
fetal RhD genotyping.
It is a cliché but nevertheless true that one can elim-
inate the risk of death from a disease only if one can
prevent it. In 1900 passive administration of antibod-
ies to the mother was found to prevent active immu-
nization, and in 1960, 20 years after the discovery
of the Rh blood-group system, experiments and
subsequent clinical trials established that Rh isoim-
munization could be prevented by the administra-





globulin — containing antibodies to RhD. The
product was licensed for administration in North
America in 1968. Today, the standard dose is 300 µg
in the United States and 100 to 125 µg elsewhere.





globulin prevents RhD isoimmunization is unknown.
Prevention does not appear to be due simply to clear-
ance of RhD-positive fetal red cells or to binding the
antibody to antigenic sites on the red-cell membrane.





must be given to an RhD-negative woman after she
has given birth to an RhD-positive infant. Unless the
father of the child is known to be RhD-negative, such





 after abortion or threatened abor-
tion, and after amniocentesis or chorionic-villus sam-
pling or any other invasive intrauterine procedure. In
the event of a transplacental hemorrhage of more
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than 30 ml of fetal blood (determined by fetal red-
cell screening with the Kleihauer–Betke test), which





immune globulin must be at least 10 µg per milliliter
of fetal blood in the maternal circulation. If all aspects
of Rh prophylaxis are considered, the prevalence of





 which in Manitoba translated to a change from
a total of 90 to 100 deaths annually in the 1940s to
1 death every two years in the 1990s.
Thus, great strides have been made in the ability
to determine fetal RhD status and in the prevention
and management of RhD isoimmunization. None-
theless, since there will always be a small number of
RhD-immunized pregnant women and because there
are no means of preventing isoimmunization in the
case of atypical blood groups (the c and Kell blood
groups in particular), there will always be a need to
maintain the investigative and fetal-transfusion skills
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AR, famine, pestilence, and poverty have had
obvious and devastating effects on health
throughout human history. In recent times, human
rights have come to be viewed as essential to free-
dom and individual development. But it is only since
the end of World War II that the link between hu-





 The 50th anniversary of the
Universal Declaration of Human Rights — signed on
December 10, 1948 — provides an opportunity to
review its genesis, to explore the contemporary link
between health and human rights, and to develop
effective human-rights strategies in order to promote
health and prevent and treat disease.
 
WAR AND HUMAN RIGHTS
 
The modern human-rights movement was born
from the devastation of World War II. Nonetheless,
appeals to universal human rights are at least as old




 in Nazi-occupied Paris in early 1944, the
French audience applauded the performance, identi-
fying Antigone with the French resistance. Antigone
was sentenced to be buried alive for defying King Cre-
on’s order not to bury her dead brother (whom the
king considered a traitor) but to leave his body to rot
in public. The Nazis in the audience also applauded
the performance, apparently because they identified
with Creon and his difficulty in maintaining law and








 which was written more than 2400
years ago, focuses on a central moral question: Is there
a higher, universal law to which all humans must an-
swer, or is simply obeying the written law of one’s
country sufficient? Antigone justified her defiance of
the king on the basis of an unwritten, higher law:
 
Nor did I think your edict had such force
that you, a mere mortal, could override the gods, 




The source of higher law has varied throughout
human history and has included the mythical gods of
Olympus, the God of the Old Testament, the God
of the New Testament, human reason, and respect
for human dignity. The multinational trial of the
Nazi war criminals at Nuremberg after World War II
was held on the premise that there is a higher law of
humanity (derived from rules of “natural law” that
are based on an understanding of the essential na-
ture of humans) and that persons may be properly
W
 
tried for violating this law. Universal criminal law
concerns crimes against humanity, such as state-





the orders of superiors is no defense: the state can-





 Another major step toward incor-
porating human rights into international law was
taken when the Universal Declaration of Human




The United Nations was formed at the end of
World War II as a permanent peace-keeping organi-
zation. The charter of the United Nations, signed by
the 50 original member nations in San Francisco on
June 26, 1945, spells out the organization’s goals.
The first two goals are “to save succeeding genera-
tions from the scourge of war . . . and to reaffirm
faith in fundamental human rights, in the dignity
and worth of the human person, in the equal rights
of men and women and of nations large and small.”7
After the charter was signed, the adoption of an in-
ternational bill of rights with legal authority pro-
ceeded in three steps: a declaration, a treaty-based
covenant, and implementation measures.
THE UNIVERSAL DECLARATION 
OF HUMAN RIGHTS
The Universal Declaration of Human Rights was
adopted by the United Nations General Assembly in
1948, with 48 member states voting in favor of
adoption and 8 (Saudi Arabia, South Africa, and the
Soviet Union together with 5 other countries whose
votes it controlled) abstaining.8 The declaration was
adopted as a “common standard for all people and
nations.”9 As Steiner notes, “No other document has
so caught the historical moment, achieved the same
moral and rhetorical force, or exerted so much influ-
ence on the human rights movement as a whole.”10
The rights enumerated in the declaration “stem from
the cardinal axiom that all human beings are born
free and equal, in dignity and rights, and are endowed
with reason and conscience. All the rights and free-
doms belong to everybody.”6 These points are
spelled out in Articles 1 and 2. Nondiscrimination is
the overarching principle. Article 7, for example, is
explicit: “All are equal before the law and are enti-
tled without any discrimination to equal protection
of the law.”8 Other articles prohibit slavery, torture,
and arbitrary detention and protect freedom of ex-
pression, assembly, and religion, the right to own
property, and the right to work and receive an edu-
cation. Of special importance to health care profes-
sionals is Article 25, which states, in part, “Everyone
has the right to a standard of living adequate for the
health and well-being of himself and his family, in-
cluding food, clothing, housing and medical care
and necessary social services.”8
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Human rights are primarily rights individuals have
in relation to governments. Human rights require gov-
ernments to refrain from doing certain things, such
as torturing persons or limiting freedom of religion,
and also require that they take actions to make peo-
ple’s lives better, such as providing education and
nutrition programs. The United Nations adopted the
Universal Declaration of Human Rights as a state-
ment of aspirations. The legal obligations of govern-
ments were to derive from formal treaties that mem-
ber nations would individually sign and incorporate
into domestic law.
THE TREATIES
Because of the Cold War, with its conflicting ide-
ologies, it took almost 20 years to reach an agree-
ment on the texts of the two human-rights treaties.
On December 16, 1966, both the International
Covenant on Civil and Political Rights and the In-
ternational Covenant on Economic, Social, and Cul-
tural Rights were adopted by the General Assembly
and offered for signature and ratification by the
member nations. The United States ratified the In-
ternational Covenant on Civil and Political Rights in
1992, but not surprisingly, given our capitalist eco-
nomic system with its emphasis on private property,
we have yet to act on the International Covenant on
Economic, Social, and Cultural Rights. The division
of human rights into two separate treaties illustrates
the tension between liberal states founded on civil
and political rights and socialist and communist wel-
fare states founded on solidarity and the govern-
ment’s obligation to meet basic economic and social
needs.
The rights spelled out in the International Cove-
nant on Civil and Political Rights include equality,
the right to liberty and security of person, and free-
dom of movement, religion, expression, and associ-
ation. The International Covenant on Economic,
Social, and Cultural Rights focuses on well-being, in-
cluding the right to work, the right to receive fair
wages, the right to make a decent living, the right to
work under safe and healthy conditions, the right to
be free from hunger, the right to education, and “the
right of everyone to the enjoyment of the highest at-
tainable standard of physical and mental health.”
Given the horrors of poverty, disease, and civil wars
over the past 50 years, it is easy to dismiss the rights
enunciated in these documents as empty gestures.
Indeed, Amnesty International, in marking the 50th
anniversary of the Universal Declaration of Human
Rights, has labeled the rights it articulates “little more
than a paper promise” for most people in the
world.11 It is certainly true that unadulterated cele-
bration is not in order, but as Kunz noted almost 50
years ago in writing about the birth of the declara-
tion, “In the field of human rights as in other actual
problems of international law it is necessary to avoid
the Scylla of a pessimistic cynicism and the Charybdis
of mere wishful thinking and superficial optimism.”6
HUMAN RIGHTS AND HEALTH
The Universal Declaration of Human Rights and
the two subsequent treaties form a global human-
rights framework for action and have a special rele-
vance for global health.1-3 In recent years, the rela-
tion between health and human rights has been most
persuasively articulated and tirelessly championed by
Dr. Jonathan Mann, the first director of the World
Health Organization’s Global Program on AIDS,
whose life was tragically cut short in the September
1998 crash of Swissair flight 111. The strongest pre-
dictor of health is income — that is, poverty is
strongly correlated with disease and disability — and
one way to attack disease and improve health inter-
nationally is to redistribute income.12 This seems a
hopeless goal to most people in developing nations.
Reliance on income redistribution as a single or pri-
mary strategy can lead to pessimism about the pos-
sibility that anything can be done or cynicism about
the likelihood that anything will be done.12,13 Equal-
ity of income may be unattainable. But it is not un-
reasonable to expect the rich to share their wealth
with the poor, and thereby help create the condi-
tions necessary for good health for all. The United
Nations has noted, for example, that the cost of uni-
versal access to basic education, health care, food,
and clean water is only $40 billion a year — less than
4 percent of the combined wealth of the 225 richest
people in the world.14 This figure seems too low (if
2 billion people needed additional resources, it would
provide only $20 for each); nonetheless, it focuses on
proper global goals and suggests that not much redis-
tribution is required to have a major impact on the
lives of most people in the world.
Multinational corporations should be actively in-
volved in promoting human rights as well, because
they control much of the wealth of the world. This
has become evident in the global environmental
movement in the areas of pollution, resource conser-
vation, and global warming, and should be evident
in the area of health care as well. Much of the agenda
for research on drugs and vaccines, for example, is
controlled by large multinational corporations, not
by governments.
By broadening our perspective, the language of
human rights highlights basic needs, such as equality,
education, nutrition, and sanitation. Improvement in
each of these areas can have a major role in improv-
ing health. Over the past decade, the World Bank has
become involved in international health. In 1993,
the World Bank issued a report entitled Investing in
Health.15 Although not stated in the language of hu-
man rights, the report’s agenda for action implicitly
acknowledged that only the recognition of basic hu-
man rights could improve the health status of most
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of the world’s population. In low-income countries,
for example, the World Bank’s two primary recom-
mendations for improvement of health were “in-
creased investment in schooling for girls” and the fi-
nancing and delivery of a basic package of public
health programs, including AIDS prevention.15 The
other major recommendations included increasing the
income of the poor, promoting the rights and status
of women through “political and economic empow-
erment and legal protection against abuse,” and deliv-
ering essential clinical services to the poor.15 These
recommendations directly address the human-rights
issues of access to education, access to health care,
and discrimination against women.
HUMAN RIGHTS AND PUBLIC HEALTH
World War II, arguably the first truly global war,
led many nations to acknowledge the universality of
human rights and the responsibility of governments
to promote them. Mann perceptively noted that the
AIDS epidemic can be viewed as the first global ep-
idemic, because it is taking place at a time when all
countries are linked both electronically and by easy
transportation.16 Like World War II, this tragedy re-
quires us to think in new ways and to develop effec-
tive methods to prevent and treat disease on a global
level. Globalization is a mercantile and ecologic fact;
it is also a reality in health care. The challenge facing
medicine and health care is to develop a global lan-
guage and strategy to improve the health of all the
world’s citizens.17
Clinical medicine is practiced one patient at a time.
The language of medical ethics is the language of
self-determination and beneficence: doing what is in
the best interests of the patient with the patient’s in-
formed consent. This language is powerful, but of-
ten has little application in countries where physi-
cians are scarce and medical resources very limited.
Public health deals with populations and preven-
tion of disease — the necessary frame of reference in
the global context. In the context of clinical practice,
the treatment of human immunodeficiency virus in-
fection with a combination of antiviral medicines
makes sense. In the context of worldwide public
health, however, such treatment may be available to
less than 5 percent of people with AIDS.18 To con-
trol AIDS, it has become necessary to deal directly
with discrimination, immigration status, and the
rights of women, as well as with the rights of privacy,
informed consent, education, and access to health
care. It is clear that population-based prevention is
required to address the AIDS epidemic effectively on
a global level (as well as, for example, tuberculosis,
malaria, and tobacco-related illness). Nonetheless, it
has been much harder to articulate a global public
health ethic. The field of public health itself has had
an extraordinarily difficult time developing its own
ethical language.19,20 This problem of language has
two basic causes: the incredibly large array of factors
that influence health at the population level, and the
emphasis by contemporary public health profession-
als on individualism and market forces rather than on
the collective responsibility for social welfare.19,21 Be-
cause of its universality and its emphasis on equality
and dignity, the language of human rights is well
suited to public health.
On the 50th anniversary of the Universal Decla-
ration of Human Rights, I suggest that the declara-
tion itself sets forth the ethics of public health, since
its goal is to provide the conditions under which
people can flourish. This is also the goal of public
health. The unification of public health and human-
rights efforts throughout the world could be a pow-
erful force to improve the lives of every person. In
my view, the declaration is a much more powerful
public health document in 1998 than it was in 1948,
because global interdependence and human equality
are better recognized today.
HUMAN RIGHTS AND PHYSICIANS
Both medical ethics and human rights represent
aspirations that are difficult to enforce.21 Over the past
two decades, medical ethics has been transformed
into medical law, with more litigation and regula-
tion. In the United States, for example, medical or-
ganizations, hospitals, and health plans often em-
phasize avoiding legal liability rather than doing the
best or right thing.22 The domain of medical ethics
is shrinking.
The domain of human rights, on the other hand,
is growing. Not only are human rights being taken
more seriously by governments, but they are also be-
coming a major driving force in private, nongovern-
mental organizations. Of course, there are different
kinds of rights and different ways to enforce them,
some of which are more effective than others. Earlier
this year, for example, at a meeting in Rome held
under the auspices of the United Nations, the coun-
tries in attendance voted overwhelmingly (120 to 7)
to propose the establishment of a permanent Inter-
national Criminal Court with jurisdiction over war
crimes, crimes against humanity, genocide, and ag-
gression.23,24 The United States refused to support
the establishment of the court unless it could, among
other things, veto trials of Americans, especially Amer-
ican troops acting abroad.23 But this condition, of
course, is incompatible with the entire purpose of
the court: to punish violations of basic human rights
regardless of the perpetrator. The court will be es-
tablished without U.S. involvement if it is ratified by
60 nations by the end of the year 2000.23
Individuals and nongovernmental organizations can
use the language and concepts of human rights to
energize their own activities. Many groups of physi-
cians have taken the lead in promoting human rights,
including International Physicians for the Preven-
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tion of Nuclear War and its U.S. affiliate, Physicians
for Social Responsibility, Physicians for Human
Rights, Médecins sans Frontières (Doctors without
Borders), and Médecins du Monde (Physicians of the
World). Global Lawyers and Physicians (of which I
am a cofounder) broadens the base by providing an
opportunity for physicians and lawyers to work to-
gether to promote human rights in health care.2,16,17
The Consortium for Health and Human Rights
(http://www.healthandhumanrights.org) has pro-
vided a new forum for cooperative action among
health-related nongovernmental organizations. Oth-
er groups, such as Amnesty International and the
National Academy of Sciences Committee on Hu-
man Rights, have developed very effective letter-
writing campaigns on behalf of persons who have
been arbitrarily detained and imprisoned. Physicians
interested in promoting human rights thus have
many organizations they can support. Most of these
organizations have concentrated on the medical con-
sequences of wars, torture, abuses of prisoners, and
arbitrary detention, as well as the threats to health
posed by nuclear, chemical, and biologic weapons,
land mines, and other means of killing and maiming.2
The fact that the Universal Declaration of Human
Rights is a declaration, not a treaty, need not limit
its reach to human-rights violations involving crimes
against humanity any more than the reach of the
Declaration of Independence has been limited by
this fact. Although the Declaration of Independence
started a war and the Universal Declaration of Hu-
man Rights was drafted to prevent war, it is the pow-
er of the concepts and language that matters most.
As Maier has noted, the Declaration of Independ-
ence “rests less in law than in the minds and hearts
of the people, and its meaning changes as new
groups and new causes claim its mantle.”25 Lincoln,
for example, claimed to be upholding the “all men
are created equal” pronouncement of the declara-
tion both when he spoke at Gettysburg and when
he issued the Emancipation Proclamation.25,26 And
a century later, Martin Luther King, Jr., stood at the
site of the Lincoln Memorial and invoked the words
of the Declaration of Independence in calling for a
new birth of the freedom Lincoln had promised, by
which he meant “an end to the poverty, discrimina-
tion, and segregation that left black citizens ‘lan-
guishing in the corners of American society,’ exiles
in their own land.”26 The meaning of the Universal
Declaration of Human Rights will also be invoked
and reinterpreted to meet the changing challenges
of the times. The agenda for human rights should
be broad; it should include efforts to make basic
health care available to everyone and to prevent dis-
ease and injury and promote health worldwide. Fifty
years after the signing of the Universal Declaration
of Human Rights, the language of human rights
pervades international politics, law, and morality.
The challenge now is to make the promise of the
Universal Declaration of Human Rights a reality.
GEORGE J. ANNAS, J.D., M.P.H.
Boston University School of Public Health
Boston, MA 02118
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